These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8746074)

  • 1. Can systematic research of hormone and growth factor receptors contribute to the recognition of acute and chronic types of breast cancer, of their specific mammary dysplasias, and of specific treatments?
    Mathé G
    Biomed Pharmacother; 1995; 49(9):385-8. PubMed ID: 8746074
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone receptors in breast cancer.
    Br Med J; 1978 Jul; 2(6130):77-8. PubMed ID: 208709
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
    Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
    J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the role of progesterone receptors in breast cancer.
    Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
    J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
    [No Abstract]   [Full Text] [Related]  

  • 5. Time for reappraisal of progesterone-receptor testing in breast cancer management.
    MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
    J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1.
    Ueda S; Tsuda H; Sato K; Takeuchi H; Shigekawa T; Matsubara O; Hiraide H; Mochizuki H
    Cancer Sci; 2006 Jul; 97(7):597-604. PubMed ID: 16827799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
    Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
    J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological detection of hormone and growth factor receptors in breast cancer.
    Kölble K
    Recent Results Cancer Res; 2007; 176():201-9. PubMed ID: 17607927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunohistochemical detection of steroid hormone receptors in breast cancer: open problems and new perspectives].
    Barbareschi M; Doglioni C
    Pathologica; 2002 Jun; 94(3):115-20. PubMed ID: 12108031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of therapeutic response in breast carcinoma: predictive factors].
    Nesković-Konstantinović Z
    Srp Arh Celok Lek; 1999; 127(3-4):131-6. PubMed ID: 10500437
    [No Abstract]   [Full Text] [Related]  

  • 12. Progesterone receptor testing: not the right time to be buried.
    Colozza M; Larsimont D; Piccart MJ
    J Clin Oncol; 2005 Jun; 23(16):3867-8; author reply 3869-70. PubMed ID: 15923594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic factors in breast cancer patients].
    Roisman I; Peretz T; Reznick AZ; Lifshitz I; Bitterman A; Fares F; Toledano H; Barzilay A; Durst AL
    Harefuah; 1996 May; 130(10):693-9. PubMed ID: 8794662
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cytochemical detection of steroid receptors: a new tool for research in mammary oncology? (author's transl)].
    Danguy A; Leclercq G; Pattyn G; Pasteels JL; Heuson JC
    Rev Med Brux; 1981 May; 2(5):477-81. PubMed ID: 7256029
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
    Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
    Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
    Canbay E; Degerli N; Gulluoglu BM; Kaya H; Sen M; Bardakci F
    Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple negative breast cancer: clinicopathological characteristics and treatment strategies.
    Akiyama F; Iwase H
    Breast Cancer; 2009; 16(4):252-3. PubMed ID: 19506994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.